Literature DB >> 16318726

Respiratory infections during SARS outbreak, Hong Kong, 2003.

Janice Y C Lo1, Thomas H F Tsang, Yiu-Hong Leung, Eugene Y H Yeung, Thomson Wu, Wilina W L Lim.   

Abstract

The effect of community hygienic measures during the outbreak of severe acute respiratory syndrome in Hong Kong was studied by comparing the proportion of positive specimens of various respiratory viruses in 2003 with those from 1998 to 2002. Community hygienic measures significantly reduced the incidence of various respiratory viral infections.

Entities:  

Mesh:

Year:  2005        PMID: 16318726      PMCID: PMC3367357          DOI: 10.3201/eid1111.050729

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Severe acute respiratory syndrome (SARS) is an infection caused by a novel coronavirus that is transmitted primarily through direct mucous membrane contact with infectious respiratory droplets and through exposure to fomites. In 2003, Hong Kong reported SARS cases from March 11 to June 2. During the height of the outbreak, schools were suspended, social activities were curtailed with the closure of various public places, and the community was engaged in a sustained and intense hygiene campaign (–). Population education on personal hygienic measures was spearheaded by the government with concerted efforts from various organizations and the community. Surveys conducted in April and May 2003 showed that most of the population wore a face mask (76%), washed their hands after contact with potentially contaminated objects (65%), used soap when washing hands (75%), covered their mouths when sneezing or coughing (78%), and used diluted bleach for household cleaning (>50%) (,). Another survey on health-seeking behavioral traits conducted in June 2003 showed that >70% of respondents practiced some of these hygienic measures more frequently during the SARS outbreak than during the pre-SARS period ().

The Study

We postulated that these populationwide anti-SARS measures would have effects on other infections spread by the respiratory route. In this study, we examined whether such measures also affected the incidence of some common acute viral respiratory infections. The study period was January 1, 1998, to December 31, 2003. Data were obtained from the Government Virus Unit (GVU), a public health and diagnostic virology laboratory serving public and private hospitals and outpatient clinics in Hong Kong. At GVU, all respiratory specimens are routinely cultured using 4 continuous cell lines, Rhesus monkey kidney, Madin-Darby canine kidney, rhabdomyosarcoma, and human laryngeal epithelium, which could support the growth of various viruses including influenza, parainfluenza, respiratory syncytial virus (RSV), and adenovirus. On detection of specific cytopathic effects, the viruses are identified with standard protocols (). For each month of the study period, we obtained the number of respiratory virus isolates as a proportion of the total number of respiratory specimens processed by GVU. We computed the percentage change in the proportion of positive specimens (PPS) for each virus between each month of 2003 and the mean PPS in the same month of the preceding 5 years (1998–2002), which served as the reference period. For comparison purposes, we obtained the monthly number of positive tests for immunoglobulin M (IgM) antibody against hepatitis B core antigen (anti-HBc) and the corresponding total number of tests performed in the study period. The percentage change in PPS was calculated as above. Although a positive IgM anti-HBc test result indicates acute hepatitis B infection or an exacerbation of chronic hepatitis B infection, as we were testing the same catchment of population throughout 1998 to 2003, the proportion of exacerbations of chronic hepatitis B infection is assumed to have remained unchanged during the study period. The Table shows the change in PPS in 2003 for the various viruses in comparison with the reference period. In 2003, the monthly number of respiratory specimens ranged from 665 to 5,432 (mean 1,399), in comparison with a range throughout the years 1998–2002 of 757 to 3,162 (mean 1,334.5). A surge in the number of specimens was noted during March and April 2003 (5,432 and 3,758, respectively). During March to July 2003, marked reductions in PPS occurred compared with the reference period for influenza virus, parainfluenza virus, RSV, and adenovirus, particularly in the months of April, May, and June. This reduction corresponded to the period when anti-SARS measures in the community were most rigorous. In contrast, similar changes in PPS were not observed for hepatitis B, which is caused by a bloodborne virus with a different mode of transmission than that of the 4 respiratory viruses (Figure 1). Since August 2003, instead of reductions in PPS, a rebound in isolation rates was observed for the 4 viruses.
Table

Change in proportion of positive specimens (PPS) in 2003 for various viruses with reference to the period 1998–2002*

VirusJanFebMarAprMayJunJulAugSepOctNovDec
Influenza
No. isolates32741978610522589654121501035
No. tests performed1,1661,5305,4323,7581,4959747766651,2831,1931,0081,407
PPS (03)0.280.270.140.030.010.060.120.080.090.040.010.02
Average PPS (98–02)0.2350.3680.3290.1540.1270.1430.1860.1530.0630.0220.0190.044
Range of PPS (98–02)0.067–0.3210.143–0.5190.121–0.5170.065–0.2030.043–0.1940.072–0.2160.145–0.2320.123–0.1730.040–0.1050.009–0.0440.008–0.0300.022–0.110
% change†
+19
–26
–56
–82
–88
–58
–33
–47
+49
+87
–49
–44
Parainfluenza
No. isolates29357512211126296875112
No. tests performed1,1661,5305,4323,7581,4959747766651,2831,1931,0081,407
PPS (03)0.020.020.010.000.000.000.010.040.020.060.070.08
Average PPS (98–02)0.0350.0250.0220.0360.0370.0340.0230.0170.0270.0610.0810.065
Range of PPS (98–02)0.014–0.1060.014–0.0530.008–0.0460.021–0.0460.024–0.0540.026–0.0460.017–0.0340.010–0.0280.014–0.0430.025–0.1020.031–0.1490.035–0.156
% change†
–28
–8
–38
–91
–96
–97
–38
+135
–16
–7
–9
+22
RSV
No. isolates495366246385318148125
No. tests performed1,1661,5305,4323,7581,4959747766651,2831,1931,0081,407
PPS (03)0.040.030.010.010.000.000.010.080.140.040.010.00
Average PPS (98–02)0.0140.0210.0550.1040.0810.0660.0720.0940.0920.0360.0220.032
Range of PPS (98–02)0.003–0.0540.010–0.0650.037–0.0900.055–0.1550.049–0.1120.042–0.0980.038–0.1130.046–0.1260.057–0.1180.018–0.0510.001–0.0600.001–0.072
% change†
+203
+64
–78
–94
–95
–95
–86
–15
+54
+13
–47
–89
Adenovirus
No. isolates61788441501247817
No. tests performed1,1661,5305,43237581,4959747766651,2831,1931,0081,407
PPS (03)0.050.050.020.010.000.000.000.000.000.010.010.01
Average PPS (98–02)0.0340.0300.0350.0560.0550.0580.0680.0440.0380.0490.0520.074
Range of PPS (98–02)0.012–0.0580.019–0.0520.017–0.0710.012–0.1210.022–0.1100.028–0.1050.032–0.0910.029–0.0580.026–0.0540.045–0.0550.042–0.0620.058–0.093
% change†
+52
+72
–55
–81
–94
–100
–98
–93
–92
–88
–85
–84
Hepatitis B
No. of positive test results161113182013192022211520
No. of tests performed143981359997118139135120111102131
PPS (03)0.1120.1120.0960.1820.2060.1100.1370.1480.1830.1890.1470.153
Average PPS (98–02)0.1470.1320.1270.1290.1250.1560.1540.1560.1680.1440.1670.148
Range of PPS (98–02)0.083–0.2280.079–0.1900.093–0.1530.070–0.1680.085–0.1620.096–0.1880.104–0.1860.068–0.2280.086–0.2500.081–0.2330.099–0.2490.082–0.197
% change†–24–15–24+41+65–29–11–5+9+32–12+3

*RSV, respiratory syncytial virus.
†Percentage change of PPS in 2003 with respect to the average PPS from 1998 to 2002.

Figure 1

Change in proportion of positive specimens in 2003 for various viruses with reference to period 1998–2002. RSV, respiratory syncytial virus.

*RSV, respiratory syncytial virus.
†Percentage change of PPS in 2003 with respect to the average PPS from 1998 to 2002. Change in proportion of positive specimens in 2003 for various viruses with reference to period 1998–2002. RSV, respiratory syncytial virus. The 2003 SARS outbreak overlapped with the traditional seasonal peak from March to September for RSV in Hong Kong (). In 2003, the RSV peak season shifted to August–October. The accumulation of susceptible infants offset the infection control measures instituted against respiratory infections as well as the normal seasonality; as a result, RSV activity increased in the late months of 2003. Figure 2 illustrates the usual seasonal variation of the 4 respiratory viruses and their pattern from 1998 to 2003.
Figure 2

Proportion of positive specimens by month, 1998–2003, for A) influenza virus, B) respiratory syncytial virus, C) parainfluenza virus, and D) adenovirus.

Proportion of positive specimens by month, 1998–2003, for A) influenza virus, B) respiratory syncytial virus, C) parainfluenza virus, and D) adenovirus. Discerning whether the observed effects in our study were real or apparent is important. The surge in specimens during March and April 2003 suggested that physicians were more inclined to order tests for patients with respiratory symptoms at the height of the SARS outbreak. This fact could conceivably dilute PPS for respiratory viruses. However, since May 2003, the number of tests has returned to normal levels; however, PPS remained significantly decreased during May to July 2003. Thus, PPS reductions cannot be explained by a dilution effect caused by an increased number of specimens processed. Furthermore, after we controlled for the patients' age group differences, PPS for influenza virus remained depressed when compared to PPS in the reference period (data not shown). The same pattern was true for adenovirus. Population coverage for influenza vaccination in Hong Kong has been <15% throughout the study period (A. Chan, pers. comm.), so vaccination was unlikely to have resulted in reduced influenza circulation in the community. The concomitant significant reduction in PPS for all 4 respiratory viruses in the same period argues against 2003's being a milder year for influenza. Temporally, the moderation of PPS reductions since August 2003 (the last SARS case was reported on June 2) supported the hypothesis that the effects of populationwide anti-SARS measures on the incidence of respiratory viruses were real. With the recent outbreaks of highly pathogenic avian influenza among poultry in Asian countries, and the associated human infections, pandemic planning for influenza has been undertaken with renewed efforts on a worldwide basis (). In pandemic preparedness planning, control measures have traditionally focused on the use of antiviral chemotherapy and the expedient development of an effective vaccine. However, such strategies may not be feasible, especially in countries with limited resources. An effective vaccine would probably become available only during the latter phase of the pandemic. Information concerning the effects of increased social distance and communitywide hygiene measures on the incidence of common viral respiratory infections at a population level has been lacking. The SARS outbreak offers a unique opportunity to study the association. Although our study was observational and thus could not establish a causal relationship, it suggests a possible association between population-based hygienic measures and the reduced incidence of influenza and other acute viral respiratory infections. However, the relative contribution of each of these measures could not be estimated in our study. The effective implementation of such measures requires determined and sustained educational efforts from health authorities with collaboration of the public. We thus propose that stockpiling personal protective equipment and having public education campaigns on infection control practices should form an integral component in pandemic planning for the emergence of novel influenza virus strains in humans.
  3 in total

1.  Probable person-to-person transmission of avian influenza A (H5N1).

Authors:  Kumnuan Ungchusak; Prasert Auewarakul; Scott F Dowell; Rungrueng Kitphati; Wattana Auwanit; Pilaipan Puthavathana; Mongkol Uiprasertkul; Kobporn Boonnak; Chakrarat Pittayawonganon; Nancy J Cox; Sherif R Zaki; Pranee Thawatsupha; Malinee Chittaganpitch; Rotjana Khontong; James M Simmerman; Supamit Chunsutthiwat
Journal:  N Engl J Med       Date:  2005-01-24       Impact factor: 91.245

2.  The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong.

Authors:  G M Leung; T-H Lam; L-M Ho; S-Y Ho; B H Y Chan; I O L Wong; A J Hedley
Journal:  J Epidemiol Community Health       Date:  2003-11       Impact factor: 3.710

3.  Impacts of SARS on health-seeking behaviors in general population in Hong Kong.

Authors:  Joseph T F Lau; Xilin Yang; H Y Tsui; Jean H Kim
Journal:  Prev Med       Date:  2005-08       Impact factor: 4.018

  3 in total
  52 in total

1.  The effect of public health measures on the 1918 influenza pandemic in U.S. cities.

Authors:  Martin C J Bootsma; Neil M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-06       Impact factor: 11.205

2.  TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).

Authors:  Federico Martinón-Torres; Adolfo García-Sastre; Andrew J Pollard; Carlos Martín; Albert Osterhaus; Shamez N Ladhani; Octavio Ramilo; Jose Gómez Rial; Antonio Salas; F Xavier Bosch; María Martinón-Torres; Michael J Mina; James Cherry
Journal:  Hum Vaccin Immunother       Date:  2021-11-11       Impact factor: 3.452

3.  Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009.

Authors:  Peng Wu; Edward Goldstein; Lai Ming Ho; Lin Yang; Hiroshi Nishiura; Joseph T Wu; Dennis K M Ip; Shuk-Kwan Chuang; Thomas Tsang; Benjamin J Cowling
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

4.  Population-Based Pediatric Hospitalization Burden of Lineage-Specific Influenza B in Hong Kong, 2004-2014.

Authors:  Benjamin J Cowling; Peng Wu; Janice Y C Lo; Kwok-Hung Chan; Eunice L Y Chan; Vicky J Fang; Lok-Yee So; J S Malik Peiris; Susan S Chiu
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

5.  Differentiating impacts of non-pharmaceutical interventions on non-coronavirus disease-2019 respiratory viral infections: Hospital-based retrospective observational study in Taiwan.

Authors:  Andrew Po-Liang Chen; Isaac Yen-Hao Chu; Mei-Lin Yeh; Yin-Yin Chen; Chia-Lin Lee; Hsiao-Hsuan Lin; Yu-Jiun Chan; Hsin-Pai Chen
Journal:  Influenza Other Respir Viruses       Date:  2021-04-07       Impact factor: 4.380

6.  Is respiratory viral infection really an important trigger of asthma exacerbations in children?

Authors:  So-lun Lee; Shui-seng Susan Chiu; Peiris Joseph S Malik; Kwok-hung Chan; Hing-sang Wilfred Wong; Yu-lung Lau
Journal:  Eur J Pediatr       Date:  2011-03-30       Impact factor: 3.183

7.  School closures and influenza: systematic review of epidemiological studies.

Authors:  Charlotte Jackson; Emilia Vynnycky; Jeremy Hawker; Babatunde Olowokure; Punam Mangtani
Journal:  BMJ Open       Date:  2013-02-26       Impact factor: 2.692

8.  Swine flu: lessons we need to learn from our global experience.

Authors:  Peter Collignon
Journal:  Emerg Health Threats J       Date:  2011-07-05

9.  Non-pharmaceutical interventions for pandemic influenza, national and community measures.

Authors:  David Bell; Angus Nicoll; Keiji Fukuda; Peter Horby; Arnold Monto; Frederick Hayden; Clare Wylks; Lance Sanders; Jonathan van Tam
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

10.  Face mask use and control of respiratory virus transmission in households.

Authors:  C Raina MacIntyre; Simon Cauchemez; Dominic E Dwyer; Holly Seale; Pamela Cheung; Gary Browne; Michael Fasher; James Wood; Zhanhai Gao; Robert Booy; Neil Ferguson
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.